MeSH term
Frequency | Condition_Probility | Base Sequence | 13 | 0.0 |
DNA Primers | 6 | 0.0 |
Humans | 36 | 0.0 |
*NADPH Oxidase | 10 | 25.0 |
Phosphorylation | 2 | 0.0 |
Protein Binding | 5 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
Transcription, Genetic | 4 | 0.0 |
U937 Cells | 3 | 0.0 |
Adolescent | 5 | 0.0 |
Female | 21 | 0.0 |
Flow Cytometry | 3 | 0.0 |
Granulomatous Disease, Chronic/genetics | 2 | 40.0 |
Interferon Type II/*pharmacology | 2 | 0.0 |
Male | 22 | 0.0 |
Membrane Glycoproteins/*genetics | 4 | 0.0 |
Mutation | 4 | 0.0 |
Pedigree | 11 | 0.0 |
Research Support, Non-U.S. Gov't | 26 | 0.0 |
Adult | 4 | 0.0 |
Child, Preschool | 2 | 0.0 |
*Point Mutation | 2 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Cell Line, Transformed | 2 | 0.0 |
Exons | 6 | 0.0 |
Point Mutation | 4 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Child | 4 | 0.0 |
Chromosome Deletion | 3 | 0.0 |
Dosage Compensation (Genetics) | 2 | 1.0 |
Karyotyping | 2 | 0.0 |
Microsatellite Repeats | 3 | 0.0 |
X Chromosome/*genetics | 2 | 0.0 |
Blotting, Southern | 4 | 0.0 |
Genes, Recessive | 2 | 0.0 |
Polymerase Chain Reaction | 7 | 0.0 |
Syndrome | 2 | 0.0 |
*X Chromosome | 15 | 1.0 |
Introns | 2 | 0.0 |
Molecular Sequence Data | 13 | 0.0 |
Chromosome Mapping | 6 | 0.0 |
Linkage (Genetics) | 4 | 0.0 |
Lod Score | 3 | 0.0 |
Mental Retardation/*genetics | 3 | 1.0 |
Cytochrome b Group/*genetics | 4 | 33.0 |
Granulomatous Disease, Chronic/*genetics | 6 | 50.0 |
Polymorphism, Genetic | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
X Chromosome | 2 | 0.0 |
Haplotypes | 2 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Heterozygote Detection | 4 | 0.0 |
*Mutation | 2 | 0.0 |
Membrane Glycoproteins/*metabolism | 2 | 0.0 |
Phosphoproteins/*metabolism | 2 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Repressor Proteins/*metabolism | 2 | 1.0 |
Cell Differentiation | 3 | 0.0 |
Genes, Reporter | 3 | 0.0 |
NADPH Oxidase/*genetics | 3 | 30.0 |
Transfection | 3 | 0.0 |
*Chromosome Mapping | 4 | 0.0 |
*Linkage (Genetics) | 2 | 0.0 |
Animals | 9 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Comparative Study | 4 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Mice | 6 | 0.0 |
Genetic Markers | 3 | 0.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Recombination, Genetic | 2 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Nucleic Acid Hybridization | 3 | 0.0 |
Cell Line | 2 | 0.0 |
DNA Probes | 2 | 0.0 |
Superoxides/metabolism | 3 | 1.0 |
*Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Blotting, Western | 2 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Glutathione Transferase/metabolism | 2 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
